Nigeria Clinical Laboratory Services Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Nigerian Clinical Laboratory Services Market is segmented by Specialty (Clinical Chemistry Testing, Microbiology Testing, Hematology Testing, Immunology Testing, Cytology Testing, Genetic Testing, and Other Specialties) and Provider (Independent and Reference Laboratories and Hospital-based Laboratories).

Market Snapshot

CAGR
Study Period: 2018 - 2026
Base Year: 2020
CAGR: 4.7 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Nigerian clinical laboratory services market was valued at USD 504 million in 2020, and it is expected to reach USD 665 million in 2026 by registering a CAGR of 4.7% during the forecast period.

The clinical laboratory market has been affected by the ongoing COVID-19 pandemic. However, the market for COVID diagnostic services is positively impacting the market, as the number of cases is rising every day, and there is high demand for COVID diagnostic services in Nigeria. According to an article published in the International Journal of Infectious Diseases, 2020, the incidence rate of COVID-19 is growing steadily in Nigeria. The Government of Nigeria is continuously focusing on remote diagnostics, case management, and the expansion of telemedicine solutions, which may fulfill the unmet needs during the ongoing pandemic.

The Nigerian Clinical laboratory market is driven by the rising incidences of chronic diseases, the increasing demand for accurate disease diagnosis, and the government’s focus on public-private partnerships. According to the data published on the Global Health Data Exchange, the top causes of death in Nigeria are malaria, lower respiratory infections, HIV/AIDS, diarrheal diseases, cancer, meningitis, stroke, and tuberculosis. The number of malaria cases was around 58,143,458, and the number of deaths caused by malaria was around 191,106 in 2019. According to the same source, the number of tuberculosis cases was 288,258, and the number of cases for diarrheal diseases was around 244,501,556 in 2019. Thus, the prevalence of infectious diseases is rising in the country, which is augmenting the demand for diagnostic services for the better management of diseases.

In addition, the Nigerian government, donor agencies, and NGOs are also making collaborative efforts to raise awareness among individuals. In August 2019, Memfys Hospital and GE Healthcare collaborated to improve the disease diagnosis in the southeast regions of Nigeria. However, the lack of medical laboratories, advanced diagnostic equipment, and inadequately trained laboratory staff are restraining the market’s growth.

Scope of the Report

In a clinical laboratory, clinical pathology tests are carried out on collected clinical specimens for obtaining information about the patient’s health in order to aid in the diagnosis, prevention, and treatment of diseases. The Nigerian clinical laboratory services market is segmented by specialty (clinical chemistry testing, microbiology testing, hematology testing, immunology testing, cytology testing, genetic testing, and other specialties) and provider (independent and reference laboratories and hospital-based laboratories).

By Specialty
Clinical Chemistry Testing
Microbiology Testing
Hematology Testing
Immunology Testing
Cytology Testing
Genetic Testing
Other Specialties
By Provider
Independent and Reference Laboratories
Hospital-based Laboratories

Report scope can be customized per your requirements. Click here.

Key Market Trends

Microbiology Testing is Expected to Hold the Significant Market Share

By specialty, microbiology testing is anticipated to share a healthy market share during the forecast period. Microbiology testing refers to the diagnostic testing of infectious diseases caused by microorganisms, such as bacteria and viruses. The high burden of infectious diseases in Nigeria and increasing awareness of and accessibility to microbiology testing are likely to drive the segment growth in the country.

According to the UNAIDS' 2018 data, Nigeria had the second-largest HIV epidemic in the world and one of the highest rates of new infection in sub-Saharan Africa. As of 2018, 1.9 million people in Nigeria were living with AIDS; however, deaths due to AIDS have reduced significantly. AIDS-related deaths have declined since 2010, with a 26% decrease, from 72,000 deaths to 53,000 deaths, as there is increased awareness about the early diagnosis and treatment of the disease.

Similarly, according to the article published by Ahmad Muhammad Njidda, 2017 saw an increase in the rate of infectious diseases, like Lassa fever, yellow fever, monkeypox, cholera, and new strains of existing pathogens like Neisseria meningitides serogroup C in Nigeria.

Moreover, owing to the COVID 19 pandemic, there has been an increase in demand for the country's microbiology testing services. Hence, the laboratories have focused on expanding the testing capacity. For instance, in April 2020, 54Gene increased Nigeria's laboratory testing capacity for COVID-19 with a mobile laboratory in Ogun. Thus, the market for microbiology testing is likely to show growth over the forecast period in Nigeria.

tb

Competitive Landscape

The market concentration of the Nigerian clinical laboratory services market is high, and some major players are currently dominating the market. These major players include Mecure Healthcare Limited, Union Diagnostic and Clinical Services PLC, Echo-Scan Services Limited, and Synlab Bondco PLC. However, there are some mid-sized companies that are focusing on market penetration, and they are expected to hold a substantial share in the market during the forecast period.

Recent Developments

In July 2020, Clina Lancet Laboratories received approval from the Lagos State Ministry of Health for private testing of COVID-19 to expand the testing capacity in Lagos State.

In March 2020, the Nigerian genomics research, services, and development start-up, 54gene, invested USD 500,000 to tackle the current challenges around COVID-19 testing in the country.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Burden of Chronic Infectious Diseases

      2. 4.2.2 Rising Demand for Accurate Disease Diagnosis

      3. 4.2.3 Public-Private Partnerships

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Medical Laboratories and Advanced Diagnostic Equipment

      2. 4.3.2 Inadequately Trained Laboratory Staff

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Specialty

      1. 5.1.1 Clinical Chemistry Testing

      2. 5.1.2 Microbiology Testing

      3. 5.1.3 Hematology Testing

      4. 5.1.4 Immunology Testing

      5. 5.1.5 Cytology Testing

      6. 5.1.6 Genetic Testing

      7. 5.1.7 Other Specialties

    2. 5.2 By Provider

      1. 5.2.1 Independent and Reference Laboratories

      2. 5.2.2 Hospital-based Laboratories

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Mecure Healthcare Ltd

      2. 6.1.2 Union Diagnostic And Clinical Services PLC

      3. 6.1.3 Echo Lab (Integrated Diagnostic Holdings)

      4. 6.1.4 Synlab Bondco PLC

      5. 6.1.5 Afriglobal Medicare Ltd

      6. 6.1.6 Medicaid Radiology Ltd

      7. 6.1.7 Lancet Laboratories (CLINA LANCET)

      8. 6.1.8 LifeBridge Diagnostic Center

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Nigeria Clinical Laboratory Services Market market is studied from 2018 - 2026.

The Nigeria Clinical Laboratory Services Market is growing at a CAGR of 4.7% over the next 5 years.

The Nigeria Clinical Laboratory Services Market is valued at 504 Million USD in 2018.

The Nigeria Clinical Laboratory Services Market is valued at 665 Million USD in 2026.

Union Diagnostics & Clinical Services, Mecure Healthcare Limited, AfriGlobal Medicare Limited, Synlab Bondco PLC, Echolab are the major companies operating in Nigeria Clinical Laboratory Services Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!